Bill would end HIV prevention, 11 other programs and let states decide how to spend the money. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Bill would end HIV prevention, 11 other programs and let states decide how to spend the money. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

AIDS Policy Law. 1995 Feb 10;10(2):1, 10. Unique Identifier : AIDSLINE AIDS/95700160


Abstract: Under legislation proposed by Republican Senator Nancy Kassebaum (Kansas), decisions on how to spend Federal funds for HIV prevention and tuberculosis control would be shifted to the states. Kassebaum said that transforming the twelve categorical Centers for Disease Control and Prevention (CDC) grant programs into a single block grant would decrease administrative costs and give states greater flexibility in meeting their public health needs. Others who favor retaining special purpose programs are concerned that the block grant funding may be cut. AIDS activists are concerned that state lawmakers might decide not to fund prevention programs for HIV or TB because of the stigma society attaches to the people the programs would serve.
Keywords: AIDS-Related Opportunistic Infections/*PREVENTION & CONTROL Financing, Government/LEGISLATION & JURISPRUD/*ORGANIZATION & ADMIN Health Policy/LEGISLATION & JURISPRUD Human HIV Infections/COMPLICATIONS/*PREVENTION & CONTROL *Politics *State Government Tuberculosis/*PREVENTION & CONTROL United States NEWSLETTER ARTICLEKWDaids-relatedopportunisticinfections/KWDprevention&controlfinancing,government/legislation&jurisprud/KWDorganization&adminhealthpolicy/legislation&jurisprudhumanhivinfections/complications/KWDprevention&controlKWDpoliticsKWDstategovernmenttuberculosis/KWDprevention&controlunitedstatesnewsletterarticle
950930
M9591299

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .